Proxy Statement

PULSE BIOSCIENCES, INC. Filed 2026-05-11 Acc 0001437749-26-016006

Documents 1

2026-05-14 10-Q Quarterly Report
2026-05-13 SCHEDULE 13D/A Beneficial Ownership Report
2026-05-11 4/A Chief Executive Officer bought 15,000 shares at $19.69 ($295,350)
2026-05-11 4 Chief Executive Officer bought 15,000 shares at $19.69 ($295,350)
2026-05-11 4 Director bought 660,233 shares at $19.69 ($12,999,988)
2026-05-11 DEF 14A Proxy Statement
2025-10-28 DEF 14A Proxy Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading plse20260324_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…